NT-24336

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNT-24336
Drug Alias Namedimiracetam derivatives (Neurotune)NiK-003dimiracetam derivatives (Brane)NiK-13317BND-003 +[8] 
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressionNeuralgiaDiabetic Neuropathies +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNikem Research Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBrane Discovery SrlMetys PharmaceuticalsNikem Research Srl +[4] 
Active IndicationsN/A
Inactive IndicationsDepressionNeuralgiaDiabetic Neuropathies +[4] 

Other Information

ATC CodeN/A
Related LinksN/A